CHITOGEN™
MEDIFAB's proprietary ingredient made by solubilizing insoluble chitosan and applying LTG (Liquid-to-Gel) technology to create an anti-inflammatory, antioxidant, and skin-recovery environment.
Chitosan-based molecular engineering powers three distinct technology platforms — each validated through clinical evidence and global regulatory approval.
View All R&DMEDIFAB's proprietary ingredient made by solubilizing insoluble chitosan and applying LTG (Liquid-to-Gel) technology to create an anti-inflammatory, antioxidant, and skin-recovery environment.
A proprietary MEDIFAB platform that implements regenerative signals, manufactured as a dECM (Decellularized Extracellular Matrix) material by decellularizing xenogeneic dermal tissue through a supercritical CO₂ process.
A hybrid biomaterial that combines Chitogen™ — water-solubilized chitosan processed with LTG — and Regentrix™, a dECM-based platform. Designed so cells can recover on their own by shaping both conditions and signals together.
MEDIFAB provides comprehensive anti-aging solutions spanning professional medical aesthetics to everyday home care.
Skin boosters built on Medifab's proprietary platforms — Chitogen™, Regentrix™, and Chitogenix™. Combining the biocompatibility of chitosan-derived materials with regenerative technology, they work with the skin's own capacity to recover.
A lineup of medical devices including bioresorbable implants and HA fillers. Built on materials engineered to break down safely in the body, they support clinical environments that account for the full course of recovery.
res novae is a high-performance dermocosmetic brand spanning skin and scalp care. It brings Medifab's research into everyday routines, helping support balance in sensitized skin and scalp.
MEDINOVAE is a professional-use brand built on cell-boosting technology. Its formulations are designed to work at the cellular level and to integrate reliably into treatment protocols.
Global medical aesthetic and skincare company Medi-Met (CEO Cha Mi-sun) has been selected as a new certified company for the ‘2026 High Seoul Enterprise’ organized by Seoul City and the Seoul Economic Development Agency (SBA). Medi-Met CEO Cha Mi-sun (left) receives the certificate at the ‘2026 High Seoul Enterprise Certification Designation Ceremony’ organized by Seoul City and the Seoul Economic Development Agency (SBA). High Seoul Enterprise is a program that recognizes small and medium-sized companies in Seoul that have outstanding technological capabilities, product competitiveness, and growth potential…
See ArticleAt the International Congress of Aesthetic Medicine (ICAM 2026) held in Jakarta, Indonesia, PT. Star Cospharm Indonesia, the local representative of Mediplant, participated and introduced its medical aesthetic products to local medical professionals. At this conference, the Kitozan-based skin booster ‘Resnovo Crystal’ was presented to medical professionals from Indonesia and Southeast Asia…
See ArticleMedifab, a bio-health company, unveiled its chitosan-based medical aesthetic line-up on the podium at the academic conference. Medifab said on the 27th that it participated in the ‘2026 Korean Society of Obesity and Aesthetic Medicine (KOAT) Autumn Academic Conference” held at COEX in Gangnam-gu, Seoul on the 18th and demonstrated the scientific achievements and clinical value of its key chitosan-based bio products. Medifab set up a booth at the venue and…
See ArticleLeave your inquiry about distribution partnerships, product import/export, or ODM collaboration.